| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 21, 2004
Accepted on July 6, 2004
Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas 77030, USA
* To whom correspondence should be addressed. E-mail: agoulnik{at}bcm.tmc.edu.
Relaxin (RLN) is a small peptide hormone that affects a variety of biological processes. Rln1 knockout mice exhibit abnormal nipple development, prolonged parturition, age-related pulmonary fibrosis, and abnormalities in the testis and prostate. We describe here relaxin receptor Lgr7 deficient mice. Mutant females have grossly underdeveloped nipples and are unable to feed their progeny. Some Lgr7-/- females were unable to deliver their pups. Histological analysis of Lgr7 mutant lung tissues demonstrates increased collagen accumulation and fibrosis surrounding the bronchioles and the vascular bundles, absent in wild-type animals. However, Lgr7 deficient males do not exhibit abnormalities in the testes or prostate as seen in Rln1 knockout mice. Lgr7 deficient females with additional deletion of Lgr8 (Great), another putative receptor for relaxin, are fertile and have normal sized litters. Double mutant males have normal sized prostate and testes, suggesting that Lgr8 does not account for differences in Rln1-/- and Lgr7-/- phenotypes. Transgenic overexpression of Insl3, the cognate ligand for Lgr8, does not rescue the mutant phenotype of Lgr7 deficient female mice indicating non-overlapping functions of the two receptors. Our data indicate that neither Insl3 nor Lgr8 contribute to the relaxin signaling pathway. We conclude that the Insl3/Lgr8 and Rln1/Lgr7 actions do not overlap in vivo.
This article has been cited by other articles:
![]() |
J.-I. Park, J. Semyonov, C. L. Chang, W. Yi, W. Warren, and S. Y. T. Hsu Origin of INSL3-mediated testicular descent in therian mammals Genome Res., June 1, 2008; 18(6): 974 - 985. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yao, A. I. Agoulnik, P. S. Cooke, D. D. Meling, and O. D. Sherwood Relaxin Acts on Stromal Cells to Promote Epithelial and Stromal Proliferation and Inhibit Apoptosis in the Mouse Cervix and Vagina Endocrinology, May 1, 2008; 149(5): 2072 - 2079. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Feng, N. V Bogatcheva, A. Truong, B. Korchin, C. E Bishop, T. Klonisch, I. U Agoulnik, and A. I Agoulnik Developmental Expression and Gene Regulation of Insulin-like 3 Receptor RXFP2 in Mouse Male Reproductive Organs Biol Reprod, October 1, 2007; 77(4): 671 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Feng, I. U. Agoulnik, N. V. Bogatcheva, A. A. Kamat, B. Kwabi-Addo, R. Li, G. Ayala, M. M. Ittmann, and A. I. Agoulnik Relaxin Promotes Prostate Cancer Progression Clin. Cancer Res., March 15, 2007; 13(6): 1695 - 1702. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yan, A. A. Wiley, R. A. D. Bathgate, A.-L. Frankshun, S. Lasano, B. D. Crean, B. G. Steinetz, C. A. Bagnell, and F. F. Bartol Expression of LGR7 and LGR8 by Neonatal Porcine Uterine Tissues and Transmission of Milk-Borne Relaxin into the Neonatal Circulation by Suckling Endocrinology, September 1, 2006; 147(9): 4303 - 4310. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Silvertown, J. S. Walia, A. J. Summerlee, and J. A. Medin Functional Expression of Mouse Relaxin and Mouse Relaxin-3 in the Lung from an Ebola Virus Glycoprotein-Pseudotyped Lentivirus via Tracheal Delivery Endocrinology, August 1, 2006; 147(8): 3797 - 3808. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hombach-Klonisch, J. Bialek, B. Trojanowicz, E. Weber, H.-J. Holzhausen, J. D. Silvertown, A. J. Summerlee, H. Dralle, C. Hoang-Vu, and T. Klonisch Relaxin Enhances the Oncogenic Potential of Human Thyroid Carcinoma Cells Am. J. Pathol., August 1, 2006; 169(2): 617 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ferlin, N.V. Bogatcheva, L. Gianesello, A. Pepe, C. Vinanzi, A.I. Agoulnik, and C. Foresta Insulin-like factor 3 gene mutations in testicular dysgenesis syndrome: clinical and functional characterization Mol. Hum. Reprod., June 1, 2006; 12(6): 401 - 406. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Fu, P-J Shen, C-X Zhao, D J Scott, C S Samuel, J D Wade, G W Tregear, R A D Bathgate, and A L Gundlach Leucine-rich repeat-containing G-protein-coupled receptor 8 in mature glomeruli of developing and adult rat kidney and inhibition by insulin-like peptide-3 of glomerular cell proliferation. J. Endocrinol., May 1, 2006; 189(2): 397 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Bathgate, R. Ivell, B. M. Sanborn, O. D. Sherwood, and R. J. Summers International Union of Pharmacology LVII: Recommendations for the Nomenclature of Receptors for Relaxin Family Peptides. Pharmacol. Rev., March 1, 2006; 58(1): 7 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Feng, N. V. Bogatcheva, A. A. Kamat, A. Truong, and A. I. Agoulnik Endocrine Effects of Relaxin Overexpression in Mice Endocrinology, January 1, 2006; 147(1): 407 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Samuel Relaxin: Antifibrotic Properties and Effects in Models of Disease Clin. Med. Res., November 1, 2005; 3(4): 241 - 249. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. C. McGowan, S. A. Stanley, K. L. Smith, N. E. White, M. M. Connolly, E. L. Thompson, J. V. Gardiner, K. G. Murphy, M. A. Ghatei, and S. R. Bloom Central Relaxin-3 Administration Causes Hyperphagia in Male Wistar Rats Endocrinology, August 1, 2005; 146(8): 3295 - 3300. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |